Investors

banner

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Semler Scientific, Inc. Appoints Healthcare Technology Expert Wayne T. Pan, M.D., Ph.D., to its Board of Directors
PORTLAND, Ore. , May 14, 2014 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR; "Semler"), an emerging medical risk-assessment company whose mission is to develop, manufacture and market patented products that identify the risk profile of medical patients to allow healthcare providers to
View HTML
Toggle Summary Semler Scientific, Inc. Appoints Medical Device and Pharmaceutical Industry Leader Bruce J Barclay to its Board of Directors
PORTLAND, Ore. , May 6, 2014 /PRNewswire/ --  Semler Scientific, Inc. (Nasdaq: SMLR; "Semler"), an emerging medical risk-assessment company whose mission is to develop, manufacture and market patented products that identify the risk profile of medical patients to allow healthcare providers to
View HTML
Toggle Summary Semler Reports First Quarter 2014 Financial Results
-Semler builds momentum with revenue up 95% year-over-year and strengthens balance sheet with IPO proceeds-
View HTML
Toggle Summary Semler to Report First Quarter 2014 Financial Results and Host Conference Call on April 22, 2014
PORTLAND, Ore. , April 15, 2014 /PRNewswire/ --  Semler Scientific, Inc. (Nasdaq: SMLR; "Semler"), an emerging medical risk-assessment company whose mission is to develop, manufacture and market patented products that identify the risk profile of medical patients to allow healthcare providers to
View HTML
Toggle Summary Semler Scientific, Inc. Announces Closing of Initial Public Offering
PORTLAND, Ore. , Feb. 27, 2014 /PRNewswire/ --  Semler Scientific, Inc. (NASDAQ: SMLR), an emerging medical risk-assessment company whose mission is to develop, manufacture and market patented products that identify the risk profile of medical patients to allow healthcare providers to capture full
View HTML
Toggle Summary Semler Scientific Announces Pricing of Initial Public Offering of Common Stock
PORTLAND, Ore. , Feb. 20, 2014 /PRNewswire/ --  Semler Scientific, Inc. (NASDAQ: SMLR), an emerging medical risk-assessment company whose mission is to develop, manufacture and market patented products that identify the risk profile of medical patients to allow healthcare providers to capture full
View HTML

Contact Us

Semler Scientific, Inc.
911 Bern Court
San Jose, CA 95112
877-774-4211